Corpus Intelligence IC Memo — POCONO MEDICAL CENTER DICKSON CITY 2026-04-26 17:23 UTC
IC Memo — POCONO MEDICAL CENTER DICKSON CITY
Investment Committee Memorandum | PA | 40 beds | Grade C | EBITDA uplift $6.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

POCONO MEDICAL CENTER DICKSON CITY

CCN 390338 | LACKAWANNA, PA | 40 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

POCONO MEDICAL CENTER DICKSON CITY is a 40-bed suburban community hospital in LACKAWANNA, PA with $85.9M in net patient revenue and a 0.1% operating margin. The hospital serves a payer mix of 38.6% Medicare, 1.6% Medicaid, and 59.8% commercial.

Thesis: Turnaround. Our ML models identify $6.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.1% to 7.5% (+736bps).

Net Revenue HCRIS$85.9M
Current EBITDA COMPUTED$98K
Operating Margin COMPUTED0.1%
Occupancy HCRIS62.3%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS16.5%
Distress Probability ML42.1%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
81
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 0.1% places it above the state median. Among 81 size-comparable peers (20-80 beds), the median margin is 1.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 81 hospitals in the comp set.

HospitalStateBedsRevenueMargin
POCONO MEDICAL CENTER DICKSON (Target)PA40$85.9M0.1%
THE GETTYSBURG HOSPITALPA76$341.8M18.4%
UPMC HANOVERPA73$200.8M18.2%
MEMORIAL HOSPITALPA80$184.5M13.1%
UPMC CARLISLEPA72$165.0M19.5%
OSS ORTHOPAEDIC HOSPITALPA30$149.4M-5.0%
WELLSPAN SURGERY AND REHAB HOSPA25$120.2M2.8%
UPMC LITITZPA36$114.5M14.2%
MINERS MEMORIAL MEDICAL CENTERPA49$107.7M12.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.8M+210bp18mo
Cost to Collect4.5%2.5%$1.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.0M+122bp9mo
Clean Claim Rate88.0%96.0%$55K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.8M
Cost to Collect
$1.7M
Denial Rate Reduction
$1.7M
A/R Days Reduction
$1.0M
Clean Claim Rate
$55K
Total EBITDA Uplift$6.3M
Current EBITDA$98K
+ RCM Uplift+$6.3M
Pro Forma EBITDA$6.4M
Current Margin0.1%
Pro Forma Margin7.5%
WC Released (1x)$3.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$150K$63.9M424.92x235.5%
Base (11x exit)10.0x11.0x$150K$70.3M467.74x242.0%
Bull Case9.0x11.0x$135K$91.2M674.31x267.9%
Bull (12x exit)9.0x12.0x$135K$99.5M735.90x274.4%
Bear Case11.0x10.0x$165K$32.2M194.80x187.0%
Bear (11x exit)11.0x11.0x$165K$35.5M214.61x192.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 81 hospitals with 20-80 beds
  • Same-state prioritization (n=82)
  • Comp margins: P25=-12.8% / P50=1.8% / P75=9.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.